Agenus presents additional clinical responses and novel biomarker data at sitc2020

Lexington, mass., nov. 09, 2020 (globe newswire) --  agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced presentations on seven novel programs at the society for immunotherapy of cancer (sitc) 35th anniversary annual meeting & pre-conference programs (sitc 2020) on november 9-14, 2020.
AGEN Ratings Summary
AGEN Quant Ranking